QLIFE.ST
Qlife Holding AB (publ) [QLIFE.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
QLIFE.ST Stock Summary
Top 10 Correlated ETFs
QLIFE.ST
Top 10 Correlated Stocks
QLIFE.ST
In the News
QLIFE.ST Financial details
Company Rating
-
Market Cap
11.03M
Income
-159.96M
Revenue
244K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
13
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-0.12
Forward P/E
-
PEG
0.02
P/S
8.76
P/B
0.11
P/C
-
P/FCF
-0.71
Quick Ratio
0.1
Current Ratio
0.7
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.27
EPS next Y
-
EPS next Q
-
EPS this Y
-70.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-53.82%
Revenue Q/Q
-33.33%
EPS Q/Q
1179.07%
-
-
-
-
SMA20
100%
SMA50
100%
SMA100
100%
Inst Own
-
Inst Trans
-
ROA
-57%
ROE
-95%
ROC
-0.9%
Gross Margin
-2668%
Oper. Margin
-6632%
Profit Margin
-6523%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0029-0.5
52W High
-
52W Low
-
RSI
84
Rel Volume
0.01
Avg Volume
38.63M
Volume
244.47K
Perf Week
58.6%
Perf Month
108.37%
Perf Quarter
192.94%
Perf Half Y
154.08%
-
-
-
-
Beta
0.492
-
-
Volatility
0.67%, 0.84%
Prev Close
-0.4%
Price
4.98
Change
-2.35%
Company Profile
- Volume Average 38.63M
- Market Capitalization 11.03M
- Employee 13
- CEO Mr. Thomas Warthoe
- Headquarters Helsingborg,SE
- IPO Date 2020-03-02
-
Website
https://www.qlifeholding.com 
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
